Exagen (XGN) Share-based Compensation (2018 - 2026)

Exagen (XGN) has 9 years of Share-based Compensation data on file, last reported at $655000.0 in Q1 2026.

• Quarterly Share-based Compensation rose 57.07% year-over-year to $655000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 47.26% YoY) and the FY2025 annual result came in at $2.2 million, up 22.4% from the prior year.
• Share-based Compensation slipped to $655000.0 in Q1 2026, from $705000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.7 million in Q2 2022 to a low of -$2.6 million in Q3 2022.
• A 5-year average of $496000.0 and a median of $560000.0 in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation slumped 291.43% — and 2023, when it jumped 4986.67%.
• Tracing XGN's Share-based Compensation over 5 years: stood at $15000.0 in 2022, then soared by 4986.67% to $763000.0 in 2023, then slumped by 43.25% to $433000.0 in 2024, then jumped by 62.82% to $705000.0 in 2025, then declined by 7.09% to $655000.0 in 2026.
• The last three Share-based Compensation figures came in at $655000.0 (Q1 2026), $705000.0 (Q4 2025), and $593000.0 (Q3 2025), per Business Quant data.